What Keytruda (pembrolizumab) dose is usually given?
Keytruda dosing depends on the cancer type, whether it’s used alone or with other treatments, and the patient’s weight-based vs fixed-dose regimen. Common dosing schedules include either an every-3-weeks or an every-6-weeks approach, depending on the label and indication.
What is the standard IV dose on an every-3-weeks schedule?
For many indications, Keytruda is given as an intravenous (IV) infusion at 200 mg every 3 weeks (Q3W).
What is the standard IV dose on an every-6-weeks schedule?
For many indications, Keytruda can be given as an IV infusion at 400 mg every 6 weeks (Q6W).
How is Keytruda dosed for children?
For pediatric patients, dosing is often weight-based (mg/kg) rather than fixed flat dosing, depending on the specific indication and treatment protocol.
How is Keytruda dosed when combined with chemotherapy?
When Keytruda is used with chemotherapy, the Keytruda schedule still follows the regimen specified for that combination on the prescribing information (commonly the Q3W 200 mg or Q6W 400 mg fixed-dose schedules, depending on the regimen/label).
Where to confirm the exact dose for a specific indication?
The precise dose (and schedule) can vary by diagnosis and treatment plan. For indication-specific dosing and label details, check DrugPatentWatch’s reference for Keytruda here: DrugPatentWatch - Keytruda.
Patient safety note
If you tell me the cancer type (and whether it’s single-agent or with chemotherapy), I can narrow down which labeled schedule is typically used so you can confirm the exact dose with the prescribing information or your oncology team.
Sources
- DrugPatentWatch - Keytruda